Free Trial

Kestra Private Wealth Services LLC Increases Stake in Danaher Co. (NYSE:DHR)

Danaher logo with Medical background
Remove Ads

Kestra Private Wealth Services LLC raised its position in shares of Danaher Co. (NYSE:DHR - Free Report) by 11.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 17,480 shares of the conglomerate's stock after purchasing an additional 1,754 shares during the quarter. Kestra Private Wealth Services LLC's holdings in Danaher were worth $4,013,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of DHR. FMR LLC grew its stake in shares of Danaher by 15.8% in the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock worth $6,566,116,000 after acquiring an additional 3,217,631 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in Danaher by 17.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock valued at $996,141,000 after purchasing an additional 535,254 shares in the last quarter. International Assets Investment Management LLC lifted its holdings in Danaher by 40,196.5% during the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate's stock valued at $119,539,000 after purchasing an additional 428,897 shares in the last quarter. Montrusco Bolton Investments Inc. lifted its holdings in Danaher by 30.4% during the third quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate's stock valued at $465,617,000 after purchasing an additional 397,671 shares in the last quarter. Finally, Union Bancaire Privee UBP SA bought a new stake in shares of Danaher during the fourth quarter valued at approximately $74,551,000. 79.05% of the stock is currently owned by institutional investors.

Remove Ads

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company's stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 11.10% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on DHR shares. Wolfe Research upgraded shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 price objective on the stock in a research report on Thursday, October 31st. TD Cowen boosted their price objective on shares of Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a research report on Wednesday, October 23rd. UBS Group cut their price objective on shares of Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a research report on Wednesday, October 23rd. Raymond James reissued a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. Finally, Citigroup lowered their target price on shares of Danaher from $285.00 to $265.00 and set a "buy" rating for the company in a research note on Thursday, January 30th. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $278.00.

Check Out Our Latest Stock Analysis on DHR

Danaher Stock Up 1.5 %

Shares of DHR traded up $3.07 during mid-day trading on Friday, hitting $206.66. 4,791,695 shares of the company traded hands, compared to its average volume of 4,481,736. Danaher Co. has a 1-year low of $196.80 and a 1-year high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $149.26 billion, a PE ratio of 39.14, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. The business has a 50 day moving average of $230.00 and a 200 day moving average of $249.96.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the company earned $2.09 EPS. Equities research analysts anticipate that Danaher Co. will post 7.67 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.52%. Danaher's dividend payout ratio (DPR) is presently 20.45%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Best ETFs for Spring 2025: Strong and Steady Investing
Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads